ReviewACS nano2026
From Morphology to Mechanism: Cryo-Electron Microscopy Insights into Lipid Nanoparticles for RNA Delivery.
Review in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lipid nanoparticles (LNPs) have emerged as the leading delivery platform for RNA therapeutics, yet the relationship between their internal structure and biological function remains incompletely understood. Cryogenic electron microscopy (cryo-EM) has revealed a striking diversity of LNP morphologies, but a coherent framework linking structural class to formation mechanism and functional outcome has been lacking. Here, based on cryo-EM evidence, we present a systematic classification of LNP morphologies into monophasic (solid-core, multilamellar, and inverse hexagonal) and biphasic (bleb and liposomal) architectures. For each class, we dissect the mechanistic origins of assembly, explaining how ionizable lipid chemistry, helper lipid geometry, RNA cargo properties, and formulation parameters collectively determine structural outcome, and map the spatial distribution of lipid and nucleic acid components within individual particles. We then evaluate how these structural features affect biological fate, from endosomal membrane fusion and cargo release to protein corona formation and in vivo biodistribution. A central finding across the literature is that equivalent morphology does not always guarantee equivalent biological outcome; the pathway by which a given structure is formed critically shapes its intraparticle molecular organization and, consequently, its transfection efficacy. We further discuss how biological environments, particularly endosomal acidification and protein adsorption, dynamically remodel LNP structure and function. By synthesizing structural, mechanistic, and functional insights, this Review aims to establish the design principles needed to rationally engineer LNP morphology for next-generation RNA therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.